BrianPatrickTulliusMD

Pediatric Hematology & Oncology • Orlando, FL

Pediatric Hematologic Oncology

Research Medical Director for Pediatric Cellular Therapies

Overview of Dr. Tullius

Dr. Brian Tullius is a pediatric hematologist/oncologist in Orlando, FL and is affiliated with multiple hospitals in the area, including AdventHealth Orlando, Nationwide Children's Hospital, and AdventHealth for Children. He received his medical degree from University of Nebraska College of Medicine and has been in practice 9 years. He is one of 73 doctors at Nationwide Children's Hospital and one of 2 doctors at AdventHealth for Children who specialize in Pediatric Hematology & Oncology.

Office
2501 N Orange Ave
Ste 589
Orlando, FL 32804
Book by Phone+1(571) 989-6043

Fax+1 407-303-1301

Education & Training

Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2020 - 2021
Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2020
University of California Davis HealthResidency, Pediatrics, 2014 - 2017
Naval Aerospace Medical InstituteFlight Surgeon, 2009 - 2010
Naval Medical Center (San Diego)Internship, Pediatrics, 2008 - 2009
University of Nebraska College of MedicineClass of 2008

Certifications & Licensure

FL State Medical License 2021 - 2025
OH State Medical License 2017 - 2021
CA State Medical License 2015 - 2019
NE State Medical License 2010 - 2014
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant Start of enrollment: 2021 Aug 24
Enrolling by invitation
Phase 2

Publications & Presentations

PubMed

7 citations
Natural killer cells for antiviral therapy.
Davey M Smith, Jolie R Schafer, Brian Tullius, Laura Witkam, Silke Paust
Science Translational Medicine. 2023-01-04
11 citations
CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.
Ezgi Elmas, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P Tullius, Kinnari Sorathia
Frontiers in Oncology. 2022-01-01
41 citations
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.
Margaret G. Lamb, Hemalatha G. Rangarajan, Brian P. Tullius, Dean A. Lee
Stem Cell Research & Therapy. 2021-03-25

Professional Memberships

American Academy of Pediatrics - AAP
Member
American Society of Hematology - ASH
Member